Vimarsana
Biggest News Aggregation in the World

Page 18 - Jun Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jun Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jun Wang Today - Breaking & Trending Today

Some Pre-existing Mutant Strains of the Virus Causing COVID-19 May Resist Paxlovid - Vimarsana News

Some Pre-existing Mutant Strains of the Virus Causing COVID-19 May Resist Paxlovid

Doctors should reserve Paxlovid for the highest risk patients because if Paxlovid is widely used, it mostly will destroy the variants it can treat, says a Rutgers researcher.

Functional Protein Measuring Technology Could Advance Drug Discovery | - Vimarsana News

Functional Protein Measuring Technology Could Advance Drug Discovery |

A new biomedical research tool that enables scientists to measure hundreds of functional proteins in a single cell could offer new insights into cell machinery

New Functional Protein Measuring Technology Could Advance Drug Discovery Research | - Vimarsana News

New Functional Protein Measuring Technology Could Advance Drug Discovery Research |

STONY BROOK, NY, June 29, 2022 – A new biomedical research tool that enables scientists to measure hundreds of functional proteins in a single cell could offer new insights into cell machinery. Led by Jun Wang, Associate Professor of Biomedical Engineering at Stony Brook University, this microchip assay -- called the single-cell cyclic multiplex in situ tagging (CycMIST) technology – may help to advance fields such as molecular diagnostics and drug discovery. Details about the cyclic microchip assay method are published in Nature Communications. While newer technologies of single-cell o...

Research opens the door to improved treatments for congenital heart disease - Vimarsana News

Research opens the door to improved treatments for congenital heart disease

The first genomics analysis of congenital heart disease has improved our understanding of the mechanisms underlying the progression of the condition and revealed opportunities for personalized treatments.

Source: bcm.edu
Sea Limited Stock: Optimistic On Its Long-Term Trajectory (NYSE:SE) - Vimarsana News

Sea Limited Stock: Optimistic On Its Long-Term Trajectory (NYSE:SE)

Shopee has executed well, but SeaMoney TPV sequential growth is declining. So, why do we give SE stock a BUY rating? Click here to find out.